XTLB
XTL Biopharmaceuticals
XTLB
XTLB
6 hedge funds and large institutions have $1.31M invested in XTL Biopharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$64K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$141K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NC
1
Noked Capital
Tel Aviv,
Israel
| $551K | 198,888 | – | – |
|
|
NI
2
Noked Israel
Ramat Hasharon,
Israel
| $551K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $141K | 51,071 | -600 | -1% |
|
|
4
Renaissance Technologies
New York
| $64K | 23,280 | +1,000 | +4% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | – | -12,801 | Closed |
|
6
UBS Group
Zurich,
Switzerland
| $0 | 154 | -2,744 | -95% |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $0 | 153 | +153 | New |
|